NCT02883049 · OUTCOME
Induction Mortality in Patients With DS and HR B-ALL Treated With Modified Induction
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Percentage of patients
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- At 1 month
What was measured
Percentage of deaths in induction will be calculated.
Analysis population: Patients with DS and HR B-ALL treated with modified Induction
Groups in this outcome
DS HR B-ALL (Induction)
Patients with Down syndrome receive induction chemotherapy
| Group | Source count |
|---|---|
| DS HR B-ALL (Induction) | 224 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| DS HR B-ALL (Induction) | 3.57 | Not reported | 1.1 | 6.0 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1.1
- upper Limit
- 6.0
- value
- 3.57
- denoms
- counts
- group Id
- OG000
- value
- 224
- units
- Participants
- description
- Percentage of deaths in induction will be calculated.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Patients with Down syndrome receive induction chemotherapy
- id
- OG000
- title
- DS HR B-ALL (Induction)
- param Type
- NUMBER
- population Description
- Patients with DS and HR B-ALL treated with modified Induction
- reporting Status
- POSTED
- time Frame
- At 1 month
- title
- Induction Mortality in Patients With DS and HR B-ALL Treated With Modified Induction
- type
- SECONDARY
- unit Of Measure
- Percentage of patients
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle